{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:59:16Z","timestamp":1789419556083,"version":"build-2803163510"},"reference-count":37,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a rare inflammatory disorder with a poor prognosis for affected individuals. To find a means of suppressing the clinical phenotype, we investigated the cellular and molecular mechanisms leading to HLH in Unc13djinx\/jinx mice, in which cytolytic function of NK and CD8+ T cells is impaired. Unc13djinx\/jinx mutants infected with lymphochoriomeningitis virus (LCMV) present typical clinical features of HLH, including splenomegaly, elevated serum IFN\u03b3, and anemia. Proteins mediating cell-cell contact, cytokine signaling or Toll-like receptor (TLR) signaling were analyzed. We show that neither the integrin CD18, which is involved in adhesion between antigen-presenting cells and effector T cells, nor tumor necrosis factor (TNF) made nonredundant contributions to the disease phenotype. Disruption of IFN\u03b3 signaling reduced immune cell activation in Unc13djinx\/jinx mice, but also resulted in uncontrolled viral proliferation and exaggerated release of inflammatory cytokines. Abrogating the function of myeloid differentiation primary response gene 88 (MyD88) in Unc13djinx\/jinx mice suppressed immune cell activation and controlled cytokine production in an IL-1 receptor 1 (IL-1R1)\u2013independent way. Our findings implicate MyD88 as the key initiator of myeloid and lymphoid proliferation in HLH, and suggest that blockade of this signaling molecule may reduce immunopathology in patients.<\/jats:p>","DOI":"10.1182\/blood-2011-01-329607","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T00:29:12Z","timestamp":1304728152000},"page":"6582-6588","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice"],"prefix":"10.1182","volume":"117","author":[{"given":"Philippe","family":"Krebs","sequence":"first","affiliation":[{"name":"Department of Genetics, The Scripps Research Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Crozat","sequence":"additional","affiliation":[{"name":"Department of Genetics, The Scripps Research Institute, La Jolla, CA;"},{"name":"Centre d'Immunologie de Marseille-Luminy, Universit\u00e9 de la M\u00e9diterran\u00e9e, Marseille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Popkin","sequence":"additional","affiliation":[{"name":"Department of Genetics, The Scripps Research Institute, La Jolla, CA;"},{"name":"Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Oldstone","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Beutler","sequence":"additional","affiliation":[{"name":"Department of Genetics, The Scripps Research Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111711252936000_B1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPH.0b013e3181923cb4","article-title":"Experience with hemophagocytic lymphohistiocytosis\/macrophage activation syndrome at a single institution.","volume":"31","author":"Gupta","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2019111711252936000_B2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmv.638","article-title":"Viral infections associated with haemophagocytic syndrome.","volume":"20","author":"Maakaroun","year":"2010","journal-title":"Rev Med Virol"},{"issue":"4","key":"2019111711252936000_B3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/pbc.20511","article-title":"Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL).","volume":"46","author":"Ueda","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019111711252936000_B4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0105-2896.2010.00890.x","article-title":"Inherited defects in lymphocyte cytotoxic activity.","volume":"235","author":"Pachlopnik Schmid","year":"2010","journal-title":"Immunol Rev"},{"issue":"2","key":"2019111711252936000_B5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2019111711252936000_B6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.20062447","article-title":"Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.","volume":"204","author":"Crozat","year":"2007","journal-title":"J Exp Med"},{"issue":"29","key":"2019111711252936000_B7","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.0603804103","article-title":"Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.","volume":"103","author":"Jiang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111711252936000_B8","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.4049\/jimmunol.176.12.7525","article-title":"PanR1, a dominant negative missense allele of the gene encoding TNF-alpha (Tnf), does not impair lymphoid development.","volume":"176","author":"Rutschmann","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"2019111711252936000_B9","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood-2010-10-315457","article-title":"Impact of beta2 integrin deficiency on mouse natural killer cell development and function.","volume":"117","author":"Crozat","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111711252936000_B10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ni843","article-title":"Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo.","volume":"3","author":"McGavern","year":"2002","journal-title":"Nat Immunol"},{"issue":"12","key":"2019111711252936000_B11","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1128\/JVI.70.12.8997-9002.1996","article-title":"T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice.","volume":"70","author":"Christensen","year":"1996","journal-title":"J Virol"},{"issue":"3","key":"2019111711252936000_B12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.1994.tb05095.x","article-title":"Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement.","volume":"88","author":"Imashuku","year":"1994","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111711252936000_B13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000204864","article-title":"Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor.","volume":"85","author":"Ishii","year":"1991","journal-title":"Acta Haematol"},{"issue":"18","key":"2019111711252936000_B14","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1128\/JVI.75.18.8407-8423.2001","article-title":"Critical role for alpha\/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells.","volume":"75","author":"Ou","year":"2001","journal-title":"J Virol"},{"issue":"11","key":"2019111711252936000_B15","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.4049\/jimmunol.163.11.6114","article-title":"Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus.","volume":"163","author":"Nansen","year":"1999","journal-title":"J Immunol"},{"issue":"22","key":"2019111711252936000_B16","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1128\/JVI.74.22.10304-10311.2000","article-title":"Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.","volume":"74","author":"Bartholdy","year":"2000","journal-title":"J Virol"},{"issue":"3","key":"2019111711252936000_B17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2019111711252936000_B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2019111711252936000_B19","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1128\/JVI.73.6.5196-5200.1999","article-title":"Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice.","volume":"73","author":"Cantin","year":"1999","journal-title":"J Virol"},{"issue":"1","key":"2019111711252936000_B20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/JVI.01640-07","article-title":"Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88.","volume":"82","author":"Jung","year":"2008","journal-title":"J Virol"},{"issue":"6","key":"2019111711252936000_B21","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.181.6.3804","article-title":"MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.","volume":"181","author":"Rahman","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"2019111711252936000_B22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/eji.200425730","article-title":"MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.","volume":"35","author":"Zhou","year":"2005","journal-title":"Eur J Immunol"},{"issue":"6067","key":"2019111711252936000_B23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/321239a0","article-title":"Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.","volume":"321","author":"Oldstone","year":"1986","journal-title":"Nature"},{"issue":"4","key":"2019111711252936000_B24","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/JVI.01770-08","article-title":"MyD88 intrinsically regulates CD4 T-cell responses.","volume":"83","author":"Zhou","year":"2009","journal-title":"J Virol"},{"issue":"3","key":"2019111711252936000_B25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood-2004-07-2833","article-title":"Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines.","volume":"105","author":"Beadling","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111711252936000_B26","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.4049\/jimmunol.169.10.5827","article-title":"A unique mechanism for innate cytokine promotion of T cell responses to viral infections.","volume":"169","author":"Pien","year":"2002","journal-title":"J Immunol"},{"issue":"10","key":"2019111711252936000_B27","first-page":"2081","article-title":"Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis.","volume":"33","author":"Behrens","year":"2006","journal-title":"J Rheumatol"},{"issue":"4","key":"2019111711252936000_B28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2019111711252936000_B29","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/1521-4141(200106)31:6<1716::AID-IMMU1716>3.0.CO;2-X","article-title":"CD14(dim)\/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis.","volume":"31","author":"Emminger","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1","key":"2019111711252936000_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.1830200102","article-title":"Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor.","volume":"20","author":"Vink","year":"1990","journal-title":"Eur J Immunol"},{"issue":"18","key":"2019111711252936000_B31","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1128\/JVI.00155-10","article-title":"Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus.","volume":"84","author":"Zhou","year":"2010","journal-title":"J Virol"},{"issue":"7","key":"2019111711252936000_B32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20030603","article-title":"MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis.","volume":"198","author":"Shi","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"2019111711252936000_B33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ni1308","article-title":"MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA.","volume":"7","author":"Sun","year":"2006","journal-title":"Nat Immunol"},{"issue":"9","key":"2019111711252936000_B34","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.192.9.1249","article-title":"Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.","volume":"192","author":"Sevilla","year":"2000","journal-title":"J Exp Med"},{"issue":"7","key":"2019111711252936000_B35","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.174.7.3920","article-title":"Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.","volume":"174","author":"Probst","year":"2005","journal-title":"J Immunol"},{"issue":"Pt 2","key":"2019111711252936000_B36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/vir.0.004960-0","article-title":"T-cell intrinsic expression of MyD88 is required for sustained expansion of the virus-specific CD8+ T-cell population in LCMV-infected mice.","volume":"90","author":"Bartholdy","year":"2009","journal-title":"J Gen Virol"},{"key":"2019111711252936000_B37","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-11-318485","article-title":"Antiviral memory CD8 T cell differentiation, maintenance, and secondary expansion occur independently of MyD88.","author":"Rahman","year":"2011","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/24\/6582\/1340396\/zh802411006582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/24\/6582\/1340396\/zh802411006582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T13:08:06Z","timestamp":1686056886000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/24\/6582\/22292\/Disruption-of-MyD88-signaling-suppresses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,16]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2011,6,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-329607","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11740956.793509751","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.11740956.12824054","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,16]]}}}